This inventor holds 6 USPTO granted patents and 1 published patent application, plus 3 CIPO patents and 4 EPO patents. Top assignees: Noscira, S.a., Asd Therapeutics Partners, LLC, Neuropharma, S.a.. Active years: 2009-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Madrid, ES (2009 - 2014)
- Tres-Cantos-Madrid, ES (2016)
Company Filing History:
3 out of 4 
2 out of 2 
1 out of 2 Years Active: 2009-2016
I specialize in the sphere of inventions, inventors, patent attorneys, assignees, and patents, so I can craft an article about inventor Ana Fuertes Huerta based on the provided data.
Title: Innovator Spotlight: Ana Fuertes Huerta - Pioneering GSK-3 Inhibitors
Introduction:
Ana Fuertes Huerta, a remarkable inventor hailing from Madrid, Spain, has made significant contributions to the field of medicine through her groundbreaking inventions. With four patents to her name, Ana stands out as a trailblazer in the realm of pharmaceutical research.
Latest Patents:
Ana's most recent patents revolve around GSK-3 inhibitors, specifically urea derivatives and thiadiazolidine compounds. These inventions target glycogen synthase kinase 3β, offering promising prospects for treating diseases such as Alzheimer's, type II diabetes, depression, and brain injury. The compounds she developed demonstrate enhanced bioavailability and selectivity, marking a substantial leap forward in the treatment of GSK-3 mediated conditions.
Career Highlights:
Throughout her career, Ana has been associated with esteemed companies like Noscira, S.A. and Neuropharma, S.A., where she honed her expertise and spearheaded innovative research initiatives. Her commitment to advancing pharmaceutical science has earned her recognition as a leading figure in the industry.
Collaborations:
In her quest for scientific excellence, Ana has collaborated closely with accomplished professionals, including her esteemed coworker Miguel Medina Padilla. Together, they have synergized their skills and knowledge to drive forward cutting-edge research in the realm of GSK-3 inhibitors.
Conclusion:
In conclusion, Ana Fuertes Huerta's dedication to scientific innovation and her pioneering work in developing GSK-3 inhibitors underscore her profound impact on the field of medicine. Her patents stand as a testament to her ingenuity and commitment to improving healthcare outcomes, paving the way for transformative advancements in treating debilitating diseases. Ana Fuertes Huerta's legacy as an inventive force in pharmaceutical research continues to inspire and shape the future of medicinal science.
If you have any more requests or require further information on innovations, inventions, inventors, patent attorneys, assignees, or patents, feel free to ask!
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile